CME - NASDAQ

CME Group Inc.

CME·NASDAQ

$252.64

+0.84%

Financial ServicesFinancial - Data & Stock Exchanges

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$91.55B

EPS11.1800

P/E Ratio22.60

Earnings Date07/22/2026

198.55B

Assets

44%

3Y+14.0%

5Y+59.0%

10Y+186.0%

169.82B

Total Liabilities

53%

3Y+15.0%

5Y+73.0%

10Y+246.0%

28.73B

Total Equity

3Y+7.0%

5Y+9.0%

10Y+41.0%

CME Group Inc. Funding & Solvency Profile

CME · NASDAQ

Current Assets

Cash & Cash Equivalents4.42B

Net Receivables639.20M

Inventory0.00

Other Current Assets0.00

Total Current Assets5 B

Non-Current Assets

Property, Plant & Equipment573.00M

Goodwill & Intangible Assets30.30B

Long-Term Investments1.50B

Other Non-Current Assets160.86B

Total Non-Current Assets163 B

Total Assets

198.55B

Financial Health Analysis

Current Ratio

92.97x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

5.91x

High financial leverage. Heavy reliance on debt may indicate increased financial risk and potential solvency concerns.

Working Capital

5 B

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

3% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Mixed signals: Strong short-term liquidity provides comfort, but high overall leverage requires careful monitoring of debt servicing capabilities and refinancing risk.

CME Group Inc. Balance Sheet

CME • NASDAQ

CME Group Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	4.4B	2.9B	2.9B	2.7B	2.8B	1.6B	1.6B	1.4B	1.9B	1.9B	1.7B	1.4B	2.5B	1.6B	1B	855.2M	260.6M	297.9M	845.3M	969.5M
Short-Term Investments	125M	113.2M	111.7M	96M	115M	100.9M	83.2M	72.9M	90.1M	83.3M	72.5M	74.7M	68.4M	56.6M	9.4B	4.1B	6B	310.1M	203.3M	2.9B
Cash & Short-Term Investments	4.5B	3B	3B	2.8B	2.9B	1.7B	1.6B	1.4B	2B	2B	1.8B	1.4B	2.5B	1.7B	10.4B	4.9B	6.3B	608M	1B	3.9B
Net Receivables	639.2M	573.1M	535.6M	483.2M	434.5M	461.3M	491.8M	553.3M	359.7M	364.4M	357.8M	341.2M	302.7M	267.5M	289.4M	297.5M	248.3M	660.9M	194.7M	126.3M
Accounts Receivables	639.2M	573.1M	535.6M	483.2M	434.5M	461.3M	491.8M	553.3M	359.7M	364.4M	357.8M	341.2M	302.7M	267.5M	289.4M	297.5M	248.3M	234M	187.5M	121.1M
Other Receivables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	426.9M	7.2M	5.2M
Prepaids	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.3M	24.3M	17.1M
Other Current Assets	0.0	99.5B	91.3B	135.8B	158.4B	87.1B	37.4B	39.9B	44.6B	37.7B	35.8B	40.8B	21.6B	6.8B	9.6B	146.1M	165.6M	17.8B	3.7B	15.3M
Total Current Assets	5.2B	103B	94.9B	139.1B	161.8B	89.3B	39.6B	41.9B	46.9B	40B	37.9B	42.5B	24.4B	8.7B	10.9B	5.4B	6.7B	19.1B	5B	4B
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	573M	386.2M	409.5M	455.5M	505.3M	579.2M	544M	448.7M	399.7M	425.2M	491.7M	508.9M	513.4M	724M	821.9M	786.8M	738.5M	707.2M	377.5M	168.8M
Goodwill	10.5B	10.5B	10.5B	10.5B	10.5B	10.8B	10.7B	10.8B	7.6B	7.6B	7.6B	7.6B	7.6B	7.6B	8B	8B	7.5B	7.5B	5B	11.5M
Intangible Assets	19.8B	20B	20.2B	20.4B	20.7B	22B	22.3B	22.7B	19.5B	19.6B	19.7B	19.8B	19.9B	20B	20.4B	20.5B	20.2B	20.4B	9.8B	12.8M
Goodwill & Intangible Assets	30.3B	30.5B	30.7B	30.9B	31.2B	32.8B	33B	33.5B	27.1B	27.2B	27.3B	27.4B	27.5B	27.6B	28.3B	28.5B	27.8B	27.9B	14.8B	24.3M
Long-Term Investments	1.5B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Assets	124.2M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.9M
Other Non-Current Assets	160.9B	3.5B	3.7B	3.7B	3.3B	2B	2.1B	1.7B	1.4B	1.7B	1.7B	1.8B	1.9B	1.8B	653.7M	394.4M	435.8M	469.4M	108.7M	52.3M
Total Non-Current Assets	193.4B	34.4B	34.8B	35.1B	35B	35.4B	35.6B	35.6B	28.9B	29.3B	29.5B	29.7B	29.9B	30.1B	29.8B	29.7B	29B	29B	15.3B	276.3M
Total Assets	198.5B	137.4B	129.7B	174.2B	196.8B	124.7B	75.2B	77.5B	75.8B	69.4B	67.4B	72.2B	54.3B	38.9B	40.8B	35B	35.7B	48.2B	20.3B	4.3B
LIABILITIES
CURRENT LIABILITIES
Total Payables	71.8M	79.9M	90.6M	121.4M	48.8M	69.3M	61.9M	116M	31.3M	26.2M	28.7M	36.9M	36.2M	41.7M	31.1M	51.8M	46.7M	527.8M	59M	25.6M
Accounts Payable	71.8M	79.9M	90.6M	121.4M	48.8M	69.3M	61.9M	116M	31.3M	26.2M	28.7M	36.9M	36.2M	41.7M	31.1M	51.8M	46.7M	71M	59M	25.6M
Other Payables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	456.8M	0.0	0.0
Accrued Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	144.8M	148.8M	70.3M
Short Term Debt	55.8M	749.8M	0.0	16M	749.4M	0.0	0.0	574.2M	44.2B	37.5B	35.6B	40.6B	749.9M	749.7M	9.3B	420.5M	299.8M	249.9M	164.4M	521.2M
Deferred Revenue	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5M	2.9M	4.1M
Other Current Liabilities	-71.8M	101.5B	93.3B	137.6B	159.6B	88.1B	38.5B	40.6B	1.5B	1.4B	1.2B	927.5M	22.5B	6.8B	250.2M	4.3B	6.2B	17.7B	3.7B	2.1B
Total Current Liabilities	55.8M	102.3B	93.4B	137.7B	160.4B	88.2B	38.5B	41.3B	45.7B	38.9B	36.8B	41.5B	23.3B	7.6B	9.6B	4.8B	6.5B	18.6B	4.1B	2.8B
NON-CURRENT LIABILITIES
Long Term Debt	3.4B	2.7B	3.4B	3.4B	2.7B	3.4B	3.7B	3.8B	2.2B	2.2B	2.2B	2.1B	2.1B	2.1B	2.1B	2.1B	2B	3B	0.0	0.0
Deferred Tax Liabilities (Non-Current)	5.4B	5.2B	5.3B	5.4B	5.4B	5.6B	5.6B	5.7B	4.9B	7.3B	7.4B	7.3B	7.2B	7.4B	7.2B	7.8B	7.6B	7.7B	3.8B	0.0
Other Non-Current Liabilities	160.7B	721.2M	798.2M	826M	896.5M	1.1B	1.2B	745.1M	615.7M	560.9M	395.5M	376.2M	449.4M	220.5M	187.6M	191.5M	165.8M	132.7M	76.3M	32.1M
Total Non-Current Liabilities	169.8B	8.6B	9.6B	9.6B	9B	10.1B	10.5B	10.2B	7.7B	10.1B	10B	9.8B	9.8B	9.7B	9.5B	10.1B	9.8B	10.8B	3.9B	32.1M
Capital Lease Obligations	279.1M	0.0	0.0	0.0	0.0	0.0	606.3M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	169.8B	111B	103B	147.3B	169.4B	98.3B	49.1B	51.5B	53.4B	49B	46.8B	51.3B	33.1B	17.4B	19.1B	14.9B	16.4B	29.5B	8B	2.8B
SHAREHOLDERS' EQUITY
Common Stock	3.6M	3.6M	3.6M	3.6M	3.6M	3.6M	3.6M	3.6M	3.4M	3.4M	3.4M	3.4M	3.3M	3.3M	3.3M	700K	700K	700K	533K	348K
Additional Paid-In Capital	22.2B	22.4B	22.3B	22.3B	22.2B	21.2B	21.1B	21.1B	17.9B	17.8B	17.7B	17.6B	17.5B	17.2B	17.1B	17.3B	17.2B	17.1B	10.7B	405.5M
Retained Earnings	6.4B	4.2B	4.5B	4.7B	5.2B	5B	5B	4.9B	4.5B	2.5B	2.9B	3.3B	3.5B	4B	4.3B	2.9B	2.2B	1.7B	1.6B	1.1B
Accumulated Other Comprehensive Income/Loss	81.9M	-105.5M	-55.6M	-133.3M	53.5M	134.9M	3.4M	5.3M	14.3M	-14.1M	-80.8M	6.2M	152M	209.3M	111.6M	-104.1M	-126.2M	-160.3M	-3.1M	-3M
Total Stockholders' Equity	28.7B	26.5B	26.7B	26.9B	27.4B	26.3B	26.1B	25.9B	22.4B	20.3B	20.6B	20.9B	21.2B	21.4B	21.6B	20.1B	19.3B	18.7B	12.3B	1.5B
Total Equity	28.7B	26.5B	26.7B	26.9B	27.4B	26.4B	26.2B	26B	22.4B	20.3B	20.6B	20.9B	21.2B	21.5B	21.6B	20.1B	19.3B	18.7B	12.3B	1.5B
Minority Interest	0.0	0.0	0.0	0.0	0.0	31.6M	30.4M	46.8M	0.0	0.0	0.0	0.0	5.7M	86.6M	70.3M	68.1M	0.0	0.0	0.0	0.0
SUMMARY
Total Liabilities & Equity	198.5B	137.4B	129.7B	174.2B	196.8B	124.7B	75.2B	77.5B	75.8B	69.4B	67.4B	72.2B	54.3B	38.9B	40.8B	35B	35.7B	48.2B	20.3B	4.3B
Total Investments	1.6B	113.2M	111.7M	96M	115M	100.9M	83.2M	72.9M	90.1M	83.3M	72.5M	74.7M	68.4M	56.6M	47.6M	4.1B	6B	310.1M	203.3M	2.9B
Total Debt	3.8B	3.4B	3.4B	3.4B	3.4B	3.4B	3.7B	4.4B	46.4B	39.8B	37.8B	42.7B	2.9B	2.9B	11.4B	2.5B	2.3B	3.2B	164.4M	521.2M
Net Debt	-666.2M	535.6M	513.4M	718.3M	610.2M	1.8B	2.2B	3B	44.5B	37.9B	36.1B	41.3B	387.4M	1.3B	10.4B	1.7B	2.1B	2.9B	-680.9M	-448.3M
Shares Outstanding	360,596,647	360,596,647	360,596,647	360,596,647	360,596,647	360,596,647	360,596,647	360,596,647	360,596,647	360,596,647	360,596,647	360,596,647	360,596,647	360,596,647	360,596,647	360,596,647	360,596,647	360,596,647	360,596,647	360,596,647

SEC Filings

CME - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 19, 2026	May 14, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 27, 2026	April 22, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	April 24, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 22, 2026	April 22, 2026	2026	View Filing
DEF 14A DEF 14A 2025 N/A	March 23, 2026	December 31, 2025	2025	View Filing
10-K 10-K 2025 FY FY	February 26, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 04, 2026	February 04, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 02, 2026	February 02, 2026	2026	View Filing
10-Q 10-Q 2025 Q3 Q3	October 24, 2025	September 30, 2025	2025	View Filing
8-K 8-K 2025 N/A	October 22, 2025	October 22, 2025	2025	View Filing

Showing 1 to 10 of 484 filings

Related Guides

Blog Categories

Continue your CME research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.